NASDAQ$ADUS

Addus HomeCare Corporation · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Addus reported a revenue increase of 7.0% and net income of $20.2 million for Q3 2024.

Addus HomeCare announced strong third-quarter results for 2024, with a 7.0% increase in net service revenues to $289.8 million and a net income of $20.2 million, or $1.10 per diluted share. Adjusted EBITDA increased by 11.1% to $34.3 million. The company's personal care business continues to be a key growth driver.

  • Net service revenues increased by 7.0% to $289.8 million.
  • Net income was reported at $20.2 million, or $1.10 per diluted share.
  • Adjusted EBITDA increased by 11.1% to $34.3 million.
  • Cash flow from operations was $48.5 million.

Headline financials

Total Revenue

$290M

Previous: $271M+7.0%
EPS

$1.10

Previous: $1.15-4.3%
Capital Expenditures

-$4.35M

Previous: -$4.13M-5.3%
Free Cash Flow

$15.8M

Previous: $11.3M+40.2%
Net Income

$20.2M

Previous: $15.4M+30.8%
Operating Income

$26M

Previous: $22.8M+13.6%
Gross Profit

$92.2M

Previous: $86.7M+6.3%
Cash & Equivalents

$223M

Previous: $79.8M+179.4%
Total Assets

$1.15B

Previous: $1.04B+11.3%
Stock-Based Comp

$2.83M

Previous: $2.57M+10.1%

Revenue & EPS history

Addus · Revenue · Quarterly

$290M

Q3 2024+7%vs Q3 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Addus · $271M total across 3 segments · Q3 2023

  • Personal Care
    $202M+12.7%
  • Hospice
    $53.1M+3.4%
  • Home Health
    $15.7M+57.9%

Forward guidance

Addus expects to close the Gentiva acquisition in the fourth quarter of 2024 and is working on transition planning to integrate these operations. The company aims to expand its market reach, especially in Texas, and will continue to pursue acquisitions aligned with its growth strategy.

Tailwinds

  • The company will continue to maintain a conservative balance sheet.
  • Acquisitions represent a significant use of capital for Addus.
  • The company will continue to target operations that are aligned with its overall growth strategy.
  • Addus announced a definitive agreement to acquire the personal care operations of Gentiva.
  • The company is excited about the opportunity to expand its market reach, especially in Texas.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+1.2%

Avg return

Earnings day

+2.3%

Avg return

5 days after

+5.0%

Avg return

30 days after

58%

37 / 64 earnings

Positive

+23.7%

Q4 2019

Best reaction

-19.6%

Q4 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.7%-0.6%-10.6%
Q4 2025-9.1%-12.0%-17.0%
Q3 2025-5.9%-5.0%-4.1%
Q1 2025+4.1%+6.3%+7.5%
Q4 2024-10.4%-12.0%-10.1%
Q3 2024-1.7%+1.0%-2.1%
Q2 2024+3.5%+3.6%+8.5%
Q1 2024+6.5%+11.3%+16.8%
Q4 2023+3.4%+5.3%+16.4%
Q3 2023-3.7%+3.3%+7.0%
Q2 2023+1.2%+3.9%-0.1%
Q1 2023+5.8%+0.3%+10.3%
Q4 2022+3.9%+2.5%-0.4%
Q3 2022+3.1%+3.8%+4.8%
Q2 2022+3.1%+0.6%-3.9%
Q1 2022-2.3%-4.7%-4.2%
Q4 2021+20.5%+20.4%+15.8%
Q3 2021-0.5%+9.1%-8.9%
Q2 2021+9.1%+5.3%+4.0%
Q1 2021-6.6%-8.1%-10.0%
Q4 2020-11.3%-14.2%-11.3%
Q3 2020+11.9%+10.3%+4.6%
Q2 2020+2.7%-4.6%-7.1%
Q1 2020+10.2%+2.7%+22.5%
Q4 2019+23.7%+8.5%+42.1%
Q3 2019-0.9%-0.1%+8.6%
Q2 2019+1.4%+4.4%-0.2%
Q1 2019+3.6%+3.0%+8.8%
Q4 2018-2.8%-7.8%-3.8%
Q3 2018+6.5%+10.8%+16.7%
Q2 2018-4.4%-7.1%-3.4%
Q1 2018+3.1%+1.8%+11.9%
Q4 2017-0.3%+8.6%+38.5%
Q3 2017-1.4%-5.8%-7.8%
Q2 2017-0.3%-1.4%-1.3%
Q1 2017+11.3%+9.4%+2.6%
Q4 2016+1.2%+0.1%-7.5%
Q3 2016+17.4%+28.7%+32.7%
Q2 2016+13.8%+8.6%+27.1%
Q1 2016-1.1%
Q4 2015-16.6%
Q3 2015-12.7%
Q2 2015+4.4%
Q1 2015-3.4%
Q4 2014+3.7%
Q3 2014+7.1%
Q2 2014+1.3%
Q1 2014+1.8%
Q4 2013-19.6%
Q3 2013+4.3%
Q2 2013+9.3%
Q1 2013+0.9%
Q4 2012+13.2%
Q3 2012+10.5%
Q2 2012+1.1%
Q1 2011-0.0%
Q1 2012-7.8%
Q4 2011+6.6%
Q3 2010-1.3%
Q3 2011-1.3%
Q2 2011-17.3%
Q2 2010-17.3%
Q4 2010+0.2%
Q1 2010+2.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro